Carregant...
Sialidase-Based Anti-Influenza Virus Therapy Protects Against Secondary Pneumococcal Infection
BACKGROUND: DAS181 (Fludase(®)) is a sialidase fusion protein in clinical development as a broad-spectrum anti-influenza virus (IFV) therapeutics. Previous reports by others raised the concern that desialylation of airway epithelium might increase the susceptibility to Streptococcus pneumoniae infec...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2874251/ https://ncbi.nlm.nih.gov/pubmed/20170378 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/651170 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|